• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,243.34 -116.67
( -0.16%)
Global Indices
Nasdaq
51,098.17 -484.76
(-0.94%)
Dow Jones
7,440.28 -165.03
(-2.17%)
Hang Seng
66,711.59 -759.10
(-1.13%)
Nikkei 225
10,374.30 13.98
(0.13%)
Forex
USD-INR
95.73 0.01
(0.01%)
EUR-INR
111.21 0.07
(0.06%)
GBP-INR
128.58 -0.06
(-0.05%)
JPY-INR
0.60 0.00
(0.01%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

Lactose India spurts after Q4 PAT climbs 194% YoY to Rs 2 cr
May 20,2026
Revenue from operations soared 64.81% year-on-year to Rs 45.77 crore in the quarter ended 31 March 2026.

Total expenses increased 58.28% year-on-year to Rs 43.67 crore during the quarter, compared with Rs 27.59 crore in the year-ago period. The cost of materials consumed stood at Rs 28.28 crore, up 59.23% YoY, while employee benefits expenses rose 5.37% to Rs 3.53 crore.

Profit before tax (PBT) stood at Rs 2.31 crore in Q4 FY26, registering a growth of 320% from Rs 0.55 crore reported in Q4 FY25.

For the full financial year FY26, the company posted a 17.44% rise in consolidated net profit to Rs 6.06 crore, while revenue rose 40.28% to Rs 163.29 crore compared with FY25.

Lactose (India) is a pharmaceutical company engaged in the business of manufacturing, trading and carrying out job work and manufacturing of pharmaceutical products.